Probucol
Atherosclerosis, Cerebral
General Hospital of Shenyang Military RegionSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
10 Active assets in the Atherosclerosis, Cerebral cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ferumoxytol Northwestern University | Phase 4 | BB |
Rosuvastatin Samsung Medical Center | Phase 4 | BB |
Recaticimab Peking Union Medical College Hospital | Phase 4 | BB |
Lipitor General Hospital of Shenyang Military Region | Phase 4 | BB |
Rucacuzumab Peking Union Medical College Hospital | Phase 4 | BB |
View all 12 →
Same molecule, other indications
Probucol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →